TAIWAN · TWSE / TPEx
AmCad
安克 · 4188 · TPEx (OTC) · Biotech and medical
Share price, 2026-10-19NT$15.051 month +6.0% · 1 year -1.6%
Directors and supervisors hold29,634,37246.8% of shares issued
Of which pledged0.0%0
Major shareholders (10%+) hold22,155,04935.0% of shares issued
Revenue, 2026-09-62.2%year on year
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 李伊俐 | Chairman · President | 582,327 | 582,327 | 0.92% | — | — |
| 懷特生技新藥股份有限公司 | Vice chairman · Director · Major shareholder (10%+) | 22,155,049 | 22,155,049 | 34.98% | — | — |
| 李伊伶 | Vice chairman (corporate representative) | — | 100,000 | 0.16% | — | — |
| 邱淑媞 | Director (corporate representative) | — | 0 | — | — | — |
| 陳偉德 | Director (corporate representative) | — | 0 | — | — | — |
| 張金堅 | Director | 2,902,000 | 2,902,000 | 4.58% | — | — |
| 美吾華股份有限公司 | Director | 3,994,996 | 3,994,996 | 6.31% | — | — |
| 許金川 | Director (corporate representative) | — | 0 | — | — | — |
| 曾天賜 | Director (corporate representative) | — | 25,150 | 0.04% | — | — |
| 張清添 | Independent director | — | 0 | — | — | — |
| 黃文鴻 | Independent director | — | 0 | — | — | — |
| 李學禹 | Independent director | — | 0 | — | — | — |
| 林瑟宜 | Independent director | — | 0 | — | — | — |
| 沈柏岑 | Chief financial officer | — | 0 | — | — | — |
| 戴佑如 | Chief accountant | — | 0 | — | — | — |
| 黃智圓 | Other | — | 31,000 | 0.05% | — | — |